Mylan ( Mylan )

Mylan

Mylan's picture

About Mylan

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in approximately 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 18,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Mylan press release, blog etc

09/21/2018 - 00:55 Mylan Launches Authorized Generic of Ampyra Tablets
09/21/2018 - 00:49 Mylan and Biocon Announce Positive CHMP Opinion for Fulphila, Biosimilar Pegfilgrastim
09/20/2018 - 01:29 Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio, Biosimilar Adalimumab
09/17/2018 - 03:47 Print Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
09/13/2018 - 04:43 Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc Injection in Single-Dose Bags
09/11/2018 - 16:09 Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018
08/13/2018 - 02:45 Mylan Launches First Generic for Adcirca Tablets
08/07/2018 - 22:27 Statement from Mylan's Board of Directors
07/27/2018 - 16:13 Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio, Biosimilar Adalimumab
07/20/2018 - 05:36 Mylan Again Defeats Allergan's Efforts to Deny Patients Access to More Affordable Medicine
07/09/2018 - 18:57 Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon Patch
06/28/2018 - 17:39 Lupin and Mylan Partner to Commercialize Enbrel (Etanercept) Biosimilar
06/18/2018 - 06:21 Mylan Launches Generic Angiomax Injection
06/11/2018 - 17:20 Americares Honors Mylan with Power of Partnership Award
06/04/2018 - 01:49 U.S. FDA Approves Mylan and Biocon's Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta
05/16/2018 - 12:08 Mylan Announcement of Redemption of Certain Notes Due 2019
05/14/2018 - 12:55 Mylan and West Virginia University Join Forces to Inspire West Virginia Youth Through STEM-CARE
05/09/2018 - 07:08 Mylan Statement on Supply of EpiPen (epinephrine injection, USP) Auto-Injectors from Meridian Medical Technologies, a Pfizer company